Original Research
Accepted on 21 Nov 2024
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464852
Volumes
24,505 Publications
Volume 15 - 2024
Original Research
Accepted on 21 Nov 2024
Characterizing ADRs of Enfortumab vedotin and Erdafitinib in bladder cancer treatment: a descriptive analysis from WHO-VigiAccess
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503154
Original Research
Accepted on 21 Nov 2024
Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1506049
Systematic Review
Accepted on 21 Nov 2024
Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: A meta-analysis and systematic review
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1515901
Review
Accepted on 21 Nov 2024
Recent Advances in Cell Membrane-Coated Porphyrin-Based Nanoscale MOFs for Enhanced Photodynamic Therapy
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505212
Original Research
Accepted on 21 Nov 2024
Proteomic study of the inhibitory effect of Tannic acid on MRSA biofilm
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413669
Review
Accepted on 21 Nov 2024
NGF-Mediated Crosstalk: Unraveling the Influence of Metabolic deregulation on the Interplay Between Neural and Pancreatic Cancer Cells and its impact on Patient Outcomes
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499414
Original Research
Published on 21 Nov 2024
ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1423031
Original Research
Published on 21 Nov 2024
Factors influencing intrapatient variability of tacrolimus and its association with 1-year post-transplant outcomes in pediatric liver transplant recipients
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1473891
Systematic Review
Published on 21 Nov 2024
Efficacy and safety of anti-angiogenic drugs combined with chemotherapy in the treatment of platinum-sensitive/resistant ovarian cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446403
Original Research
Published on 21 Nov 2024
Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510220
- 103 views
Original Research
Published on 21 Nov 2024
Identification, screening, and comprehensive evaluation of novel thrombin inhibitory peptides from the hirudo produced using pepsin
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1460053
Original Research
Published on 21 Nov 2024
Effect of melatonin on gut microbiome and metabolomics in diabetic cognitive impairment
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1489834
- 116 views
Original Research
Published on 21 Nov 2024
The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1498031
Review
Published on 21 Nov 2024
Fermented beverages in prehispanic Chile: a comprehensive review of their phytochemistry, traditional medicinal uses, bioactivity, and social aspects
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505873
Review
Published on 21 Nov 2024
Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1455534